Design considerations for supervised consumption facilities (SCFs): Preferences for facilities where people can inject and smoke drugs

International Journal of Drug Policy

Volumn 24, Issue 2, 2013, Pages 156-163

  Watson, Tara Marie ^a   Strike, Carol ^a   Kolla, Gillian ^a   Penn, Rebecca ^a   Jairam, Jennifer ^b   Hopkins, Shaun ^c   Luce, Janine ^d   Degani, Naushaba ^b   Millson, Peggy ^a   Bayoumi, Ahmed M ^a,b,e,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c TORONTO PUBLIC HEALTH   (Canada)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Crack cocaine; Drug consumption room; Harm reduction; Stakeholders; Supervised consumption facility; Supervised injecting facility; Supervised smoking facility

Indexed keywords

COCAINE; DIAMORPHINE;

ARTICLE; CANADIAN; CONSULTATION; DECISION MAKING; DRUG USE; ETHNIC GROUP; HEALTH BEHAVIOR; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; SMOKE; SUPERVISED CONSUMPTION FACILITIES; THEMATIC ANALYSIS;

CANADA; CRACK COCAINE; DRUG USERS; FACILITY DESIGN AND CONSTRUCTION; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; SELF ADMINISTRATION;

EID: 84875380258     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2012.09.003     Document Type: Article

References (52)

1. Bayoumi A.M., Strike C., Jairam J., Watson T., Enns E., Kolla G., et al. Report of the Toronto and Ottawa supervised consumption assessment study 2012, St. Michael's Hospital and the Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario.
2. Blanken P., Hendriks V.M., van Ree J.M., van den Brink W. Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands. Addiction 2010, 105(2):300-308. 10.1111/j.1360-0443.2009.02754.x.
3. Boyd S., Johnson J.L., Moffat B. Opportunities to learn and barriers to change: Crack cocaine use in the Downtown Eastside of Vancouver. Harm Reduction Journal 2008, 5:34. 10.1186/1477-7517-5-34.
4. Brands B., Sproule B., Marshman J. Drugs and drug abuse 1998, Addiction Research Foundation, Ontario. 3rd ed.
5. Calgary addicts no longer given crack pipes. (2011). CBC News, August 19. Retrieved 30th August 2011 from . http://www.cbc.ca/news/canada/calgary/story/2011/08/19/calgary-crack-pipes-street-health.html.
6. Canadian HIV/AIDS Legal Network Legislating for health and human rights: Model law on drug use and HIV/AIDS - Module 4: Supervised drug consumption facilities 2006, Canadian HIV/AIDS Legal Network, Toronto, Retrieved 5th July 2012 from http://www.aidslaw.ca/publications/publicationsdocEN.php?ref=624.
7. Collins C.L.C., Kerr T., Kuyper L.M., Li K., Tyndall M.W., Marsh D.C., et al. Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use. Journal of Urban Health 2005, 82(2):276-284. 10.1093/jurban/jti051.
8. Collins C.L.C., Kerr T., Tyndall M.W., Marsh D.C. Rationale to evaluate medically supervised safer smoking facilities for non-injection illicit drug users. Canadian Journal of Public Health 2005, 96(5):344-347.
9. Corbin J., Strauss A. Basics of qualitative research: Techniques and procedures for developing grounded theory 2008, Sage, Thousand Oaks, CA. 3rd ed.
10. DeBeck K., Buxton J., Kerr T., Qi J., Montaner J., Wood E. Public crack cocaine smoking and willingness to use a supervised inhalation facility: Implications for street disorder. Substance Abuse Treatment, Prevention, and Policy 2011, 6:4. 10.1186/1747-597X-6-4.
11. DeBeck K., Kerr T., Lai C., Buxton J., Montaner J., Wood E. The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs. The American Journal of Drug and Alcohol Abuse 2012, 38(1):55-62. 10.3109/00952990.2011.600389.
12. DeBeck K., Kerr T., Li K., Fischer B., Buxton J., Montaner J., et al. Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs. Canadian Medical Association Journal 2009, 181(9):585-589.
13. de Jong W., Weber U. The professional acceptance of drug use: A closer look at drug consumption rooms in the Netherlands, Germany and Switzerland. International Journal of Drug Policy 1999, 10(2):99-108. 10.1016/S0955-3959(98)00072-73.
14. Dhillon, S. (2011). Insite's next battle: Supervised inhalation, May 14. The globe and mail. Retrieved 30th August 2011 from . http://www.theglobeandmail.com/news/national/british-columbia/bc-politics/insites-next-battle-supervised-inhalation/article2021966/.
15. Dubois-Arber F., Benninghoff F., Jeannin A. Typology of injection profiles of clients of a supervised drug consumption facility in Geneva, Switzerland. European Addiction Research 2008, 14(1):1-10.
16. Fischer B., Powis J., Cruz M.F., Rudzinski K., Rehm J. Hepatitis C virus transmission among oral crack users: Viral detection on crack paraphernalia. European Journal of Gastroenterology and Hepatology 2008, 20(1):29-32.
17. Haydon E., Fischer B. Crack use as a public health problem in Canada: Call for an evaluation of 'safer crack use kits'. Canadian Journal of Public Health 2005, 96(3):485-488.
18. Hedrich D. European report on drug consumption rooms 2004, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.
19. Kerr T., Tyndall M., Li K., Montaner J., Wood E. Safer injection facility use and syringe sharing in injection drug users. The Lancet 2005, 366(9482):316-318. 10.1016/S0140-6736(05)66475-6.
20. Kerr T., Wood E., Palepu A., Wilson D., Schechter M.T., Tyndall M.W. Responding to an explosive HIV epidemic driven by frequent cocaine injection: Is there a role for safe injecting facilities?. Journal of Drug Issues 2003, 33(3):579-608.
21. Khobzi N., Strike C., Cavalieri W., Bright R., Myers T., Calzavara L., et al. A qualitative study on the initiation into injection drug use: Necessary and background processes. Addiction Research and Theory 2009, 17(5):546-559. 10.1080/16066350802011664.
22. Kimber J., Dolan K., van Beek I., Hedrich D., Zurhold H. Drug consumption facilities: An update since 2000. Drug and Alcohol Review 2003, 22(2):227-233. 10.1080/095952301000116951.
23. Kimber J., Dolan K., Wodak A. Survey of drug consumption rooms: Service delivery and perceived public health and amenity impact. Drug and Alcohol Review 2005, 24(1):21-24. 10.1080/09595230500125047.
24. Leonard L., DeRubeis E. Needs assessment for a safer injecting facility in Ottawa, Canada 2008, University of Ottawa, Ottawa.
25. Leonard L., DeRubeis E., Pelude L., Medd E., Birkett N., Seto J. " I inject less as I have easier access to pipes" : Injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. International Journal of Drug Policy 2008, 19(3):255-264. 10.1016/j.drugpo.2007.02.008.
26. Lintzeris N. Prescription of heroin for the management of heroin dependence: Current status. CNS Drugs 2009, 23(6):463-476. 10.2165/00023210-200923060-62.
27. Lloyd C., Hunt N. Drug consumption rooms: An overdue extension to harm reduction policy in the UK?. International Journal of Drug Policy 2007, 18(1):5-9. 10.1016/j.drugpo.2006.12.010.
28. Macías J., Palacios R.B., Claro E., Vargas J., Vergara S., Mira J.A., et al. High prevalence of hepatitis C virus infection among noninjecting drug users: Association with sharing the inhalation implements of crack. Liver International 2008, 28(6):781-786. 10.1111/j.1478-3231.2008.01688.x.
29. Malchy L., Bungay V., Johnson J. Documenting practices and perceptions of 'safer' crack use: A Canadian pilot study. International Journal of Drug Policy 2008, 19(4):339-341. 10.1016/j.drugpo.2007.06.005.
30. Marshall B.D., Milloy M., Wood E., Montaner J.S., Kerr T. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: A retrospective population-based study. The Lancet 2011, 377(9775):1429-1437. 10.1016/S0140-6736(10)62353-7.
31. MSIC Evaluation Committee Final report on the evaluation of the Sydney Medically Supervised Injecting Centre 2003, MSIC Evaluation Committee, Sydney.
32. Porter J., Bonilla L., Drucker E. Methods of smoking crack as a potential risk factor for HIV infection: Crack smokers' perceptions and behavior. Contemporary Drug Problems 1997, 24(2):319-347.
33. Rhodes T. The 'risk environment': A framework for understanding and reducing drug-related harm. International Journal of Drug Policy 2002, 13(2):85-94. 10.1016/S0955-3959(02)00007-5.
34. Rhodes T. Risk environments and drug harms: A social science for harm reduction approach. International Journal of Drug Policy 2009, 20(3):193-201. 10.1016/j.drugpo.2008.10.003.
35. Salmon A.M., van Beek I., Amin J., Kaldor J., Maher L. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia. Addiction 2010, 105(4):676-683. 10.1111/j.1360-0443.2009.02837.x.
36. Scheinmann R., Hagan H., Lelutiu-Weinberger C., Stern R., Jarlais D.C.D., Flom P.L., et al. Non-injection drug use and hepatitis C virus: A systematic review. Drug and Alcohol Dependence 2007, 89(1):1-12. 10.1016/j.drugalcdep.2006.11.014.
37. Scherbaum N., Specka M., Schifano F., Bombeck J., Marrziniak B. Longitudinal observation of a sample of German drug consumption facility clients. Substance Use and Misuse 2010, 45(1-2):176-189. 10.3109/10826080902873044.
38. Shannon K., Ishida T., Morgan R., Bear A., Oleson M., Kerr T., et al. Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users. Harm Reduction Journal 2006, 3:1. 10.1186/1477-7517-3-1.
39. Small D. An appeal to humanity: Legal victory in favour of North America's only supervised injection facility: Insite. Harm Reduction Journal 2010, 7:23. 10.1186/1477-7517-7-23.
40. Small W., Ainsworth L., Wood E., Kerr T. IDU perspectives on the design and operation of North America's first medically supervised injection facility. Substance Use and Misuse 2011, 46(5):561-568. 10.3109/10826084.2010.517714.
41. Small W., Fast D., Krusi A., Wood E., Kerr T. Social influences upon injection initiation among street-involved youth in Vancouver, Canada: A qualitative study. Substance Abuse Treatment, Prevention, and Policy 2009, 4:8. 10.1186/1747-597X-4-8.
42. Small W., Shoveller J., Moore D., Tyndall M., Wood E., Kerr T. Injection drug users' access to a supervised injection facility in Vancouver, Canada: The influence of operating policies and local drug culture. Qualitative Health Research 2011, 21(6):743-756. 10.1177/1049732311400919.
43. Small W., Van Borek N., Fairbairn N., Wood E., Kerr T. Access to health and social services for IDU: The impact of a medically supervised injection facility. Drug and Alcohol Review 2009, 28(4):341-346. 10.1111/j.1465-3362.2009.00025.x.
44. Stillwell G., Hunt N., Taylor C., Griffiths P. The modelling of injecting behaviour and initiation into injecting. Addiction Research and Theory 1999, 7(5):447-459. 10.3109/16066359909004398.
45. Stoever H. Consumption rooms - A middle ground between health and public order concerns. Journal of Drug Issues 2002, 32(2):597-606.
46. Strathdee S.A., Navarro J.R. Commentary on Salmon et al (2010): The case for safer inhalation facilities-Waiting to inhale. Addiction 2010, 105(4):684-685. 10.1111/j.1360-0443.2010.02917.x.
47. Strauss A., Corbin J. Basics of qualitative research: Techniques and procedures for developing grounded theory 1998, Sage, Thousand Oaks, CA. 2nd ed.
48. Strike C., Watson T.M., Lavigne P., Hopkins S., Shore R., Young D., et al. Guidelines for better harm reduction: Evaluating implementation of best practice recommendations for needle and syringe programs (NSPs). International Journal of Drug Policy 2011, 22(1):34-40. 10.1016/j.drugpo.2010.03.007.
49. Trépos J.-Y Seuils d'aide et politiques d'activation. un aperçu de deux centres de réduction des dommages à Maastricht. Psychotropes 2007, 13(2):9-26.
50. Wolf J., Linssen L., de Graaf I. Drug consumption facilities in the Netherlands. Journal of Drug Issues 2003, 33(3):649-661.
51. Wood E., Tyndall M.W., Zhang R., Montaner J.S.G., Kerr T. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction 2007, 102(6):916-919. 10.1111/j.1360-0443.2007.01818.x.
52. Zurhold H., Degkwitz P., Verthein U., Haasen C. Drug consumption rooms in Hamburg, Germany: Evaluation of the effects on harm reduction and the reduction of public nuisance. Journal of Drug Issues 2003, 33(3):663-688.